Vanguard Group
PVCT

Vanguard Group’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

Vanguard Group’s Portfolio PVCT Stock Details PVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
2016
Q3 		$366K Sell
2016
Q2 		$1.38M Buy
2016
Q1 		$1.41M Buy
2015
Q4 		$1.27M Buy
2015
Q3 		$1.82M Buy
2015
Q2 		$1.67M Hold
2015
Q1 		$2.53M Hold
2014
Q4 		$2.48M Buy
2014
Q3 		$3.02M Buy